Does Cymbalta help with sweating? (+5 management tips)
By
Ivan Kahwa
Author bio
Mr Ivan Kahwa is a chemist and phytopharmaceutical scientist with expertise in chemistry, pharmacology, phytochemistry, and Nanobiotechnology. He writes and reviews content on these topics.
Mr Ivan Kahwa’s Highlights:
Guest Researcher at the University of Leipzig, Senior Research Fellow/Scientist, and Lecturer at the Department of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology.
Professional Experience:
Mr Ivan joined PHARMBIOTRAC as a research fellow/scientist during his master of science tenure. He contributed to the development of most of the phytopharmaceutical products in the project. Furthermore, he participated in carrying out the pharmacological activities of the developed products in laboratory animals such as mice and rats in order to develop proper doses hence leading to pre-clinical studies.
With the above relevant research experience, Ivan started to work with the University of Leipzig on collaborative projects with Mbarara University to develop the chemistry of Ugandan Medicinal plants and their pharmacological activities. This was coupled with several consultative positions by different German NGOs. Mr. Kahwa is also a supporting in the teaching and learning at the Departments of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine, Mbarara University of Science and Technology.
With the increase in antimicrobial resistance globally, Ivan retooled his thinking towards developing new naturally derived antibiotic regimens from Ugandan propolis with the assistance of nanotechnology to improve their delivery to microbial cells. Kahwa has also published over 28 articles in peer-reviewed journals and he is currently reviewing for many journals.
Education:
2023-2027: PhD in Pharmaceutical Sciences (ongoing) with a focus on Pharmaceutical Microbiology and Nanobiology at Mbarara University of Science and Technology.
2022: 2Msc. in Pharmacognosy and Natural Medicine Science at Mbarara University of Science and Technology.
2018: Bachelor of Science (Chemistry) at Mbarara University of Science and Technology.
Publications:
▪ Iqbal, S., Jabeen, F., Kahwa, I., & Omara, T. 2023. Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-023-09804-7
▪ Gupta, A. K., Yadav, R., Sharma, S., Sawale, J., & Kahwa, I. 2023. Anti-ageing Activity and Antioxidant Activity of Methanol Extracts of Leaves and Flowers of Salvia officinalis and Rosmarinus officinalis. Journal of Young Pharmacists, 15(3), 448–455. https://doi.org/10.5530/jyp.2023.15.60
▪ Tolo, C.U., Kahwa, I., Nuwagira, U., Weisheit, A. and Ikiriza, H., 2023. Medicinal plants used in treatment of various diseases in the Rwenzori Region, Western Uganda. Ethnobotany Research and Applications, 25, pp.1-16.
https://ethnobotanyjournal.org/index.php/era/article/view/4683
▪ Kahwa, I., Ajayi, C.O., Yadav, R., Chauhan, N.S., Shah, K., Abdelgadir, A.A., Shegena, E.A., Daniel, S., Omara, T., Asiimwe, J.B. and Ikiriza, H., 2023. Pharmacognostic and phytochemical studies as an invaluable approach for correct identification of medicinal plants: The case of Artemisia vulgaris L. substituted for Artemisia annua L. in Western Uganda. TMR Integr Med, 7, p.e23004.
https://doi.org/10.53388/TMRIM202307004
▪ Nalimu, F., Oloro, J., Kahwa, I. and Ogwang, P.E., 2021. Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, pp.1-21.
https://doi.org/10.1186/s43094-021-00296-2
▪ Elamin, O.H.S., Ali, M.A., Elgezuli, I.A.A., Bashir, M.A. and Kahwa, I., 2021. Diagnosis of pre-and post-treatment of echinococcus granulosus with counter current immune electrophoresis and bacterial co-agglutination. Journal of Microbiology and Infectious Diseases, 11(02), pp.88-94.
https://doi.org/10.5799/jmid.951600
Published book Chapter
▪ Kahwa, I., Ayesiga, I., Nakalema, S., Alinaiswe, R., Mbabazi, R. and Iqbal, S., 2023. Natural products in the management of onchocerciasis. In Natural Products in Vector-Borne Disease Management (pp. 63-80). Academic Press. Book Chapter.
https://doi.org/10.1016/B978-0-323-91942-5.00012-4
Submitted manuscripts Under Review:
▪ Comparison of the Wound Healing Activity of the Leaf and Leaf Ash Extracts of Vernonia amygdalina in Rats. Journal name: Clinical Phytoscience
▪ Ethnobotanical Survey of Medicinal plants used in the management of cancer in Uganda. Journal name: Journal of Herbal Medicine
▪ Ethnobotanical survey and phytochemical screening of medicinal plants used in treatment of epilepsy by PROMETRA-Uganda Traditional Health Practitioners in Mpigi District, Uganda. Journal name: Journal of Ethnopharmacology
Submitted book chapters under review
1.Book title: Algae as a Natural Solution for Water-Food-Energy Nexus, Section 4: Microalgae and cyanobacteria for food applications, Chapter 4.6: Safety, toxicological and allergenic aspects of using algae for food. Authors: Christine Kyarimpa, Tom Omute, Caroline K. Nakiguli, Alice V. Khanakwa4, Christopher Angiro, Ivan Kahwa, Fortunate Ahumuza, Timothy Omara*. Publisher: Springer Nature Singapore Pte Ltd. 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore.
2.Book title: Nutraceuticals Inspiring the Contemporary Therapy for Lifestyle Diseases. Chapter: Nutraceutical applications of Seaweeds and their Phytocompounds in Nutrition and Treatment of Diseases. Authors: Ivan Kahwa, Timothy Omara , Innocent Ayesiga , Gael Noel Neh Neba Ambe , Zehbanaz Javidbhai Panwala , Rachel Mbabazi , Shabnoor Iqbal , Christine Kyarimpa , Christine Betty Nagawa , Kamal Shah ,Nagendra Singh Chauhan* Publisher: CRC Press
You can view my works on the following professional sites:
Research Gate: https://www.researchgate.net/profile/Ivan-Kahwa
Google Scholar: https://scholar.google.com/citations?user=tOwrvqoAAAAJ&hl=en
ORCID: https://orcid.org/0000-0002-6440-3437
Linkedin: https://de.linkedin.com/in/ivan-kahwa-865450159
In this article, we will discuss whether Cymbalta helps with sweating. We will also explore research studies linking Cymbalta to sweating, as well as management tips for excessive sweating.
Does Cymbalta help with sweating?
No, Cymbalta does not help with sweating; instead, research studies have reported the occurrence of sweating as a side effect of this medication. Cymbalta is used in the management of mental disorders and other conditions like fibromyalgia and chronic pain.
It can cause various side effects in individuals, such as nausea, vomiting, diarrhea, sleep disturbances, weight changes, headache, dizziness, and sweating. However, there is no research evidence showing the use of Cymbalta in managing excessive sweating.
Cymbalta is an antidepressant medication primarily used in the management of depression and anxiety. It helps alleviate symptoms of these mental disorders by elevating the levels of serotonin and norepinephrine in the brain (1).
What does research suggest?
Research studies do not provide any evidence of the use of Cymbalta in managing sweating. However, these studies have reported the incidence of excessive sweating in individuals who use this medication.
According to a research study, the use of Cymbalta in patients with underlying depression was continued for 2 to 3 months. The results demonstrated the effectiveness of Cymbalta in managing depression and its associated symptoms. However, sweating was among the frequently reported side effects (2).
In another study involving patients with chronic back pain, a daily dose of 120 mg of Cymbalta was used for the symptomatic management of their symptoms. The results showed the benefits of Cymbalta in treating pain; however, the higher dosage of Cymbalta was linked to the occurrences of various side effects, including excessive sweating, nausea, dizziness, and fatigue (3).
What to do if Cymbalta causes excessive sweating?
The side effects of Cymbalta, including sweating, typically occur during the initial phase of treatment, and these side effects often subside as the body adjusts to the medication.
However, if you experience excessive sweating even after 2 to 3 weeks of treatment, you should report it to your healthcare provider. They may examine your overall symptoms and determine the appropriate intervention.
If the higher dosage of Cymbalta is associated with excessive sweating, they might suggest a reduction in dosage, which may prove beneficial in most cases.
If you continue to experience excessive sweating even with a lower dosage of Cymbalta, and it is impacting your quality of life, your healthcare provider may suggest gradually stopping the medication and starting an alternative medication that has a lower risk of causing sweating. Such medications may include bupropion, nortriptyline, or desipramine.
What are the management tips for excessive sweating?
Excessive sweating can be caused by various factors, including certain medications and medical conditions. However, there are several management tips that can help you control excessive sweating and improve your quality of life.
Use of antiperspirants
One of the most effective ways to manage excessive sweating is to apply antiperspirants to areas prone to sweating. You can various antiperspirants that can help reduce sweat production.
Lifestyle modifications
Another useful tip is to wear breathable clothing made of natural fabrics like cotton. These materials allow better air circulation and minimize sweating. Avoid tight clothes made of synthetic fabrics that trap heat and moisture and can worsen sweating.
Proper hydration is also essential for managing excessive sweating. Make sure to drink plenty of fluids throughout the day, especially water and electrolyte-rich drinks like coconut water.
Consult your healthcare provider
If these management tips do not provide sufficient relief, consult with a healthcare professional about prescription medications like anticholinergics that can help control excessive sweating.
However, if sweating is persistent and accompanied by other side effects of a medication, your healthcare provider may suggest dosage adjustment or discontinuation of the medication to prevent symptom worsening.
Remember, excessive and persistent sweating can be a challenging condition to manage, but with the help of a healthcare professional, you can take control and improve your quality of life.
In my opinion, Cymbalta should not be used for the management of sweating, as it is an antidepressant medication primarily prescribed for mental disorders. Using Cymbalta for sweating may potentially worsen symptoms, as sweating is a known side effect associated with this medication.
Was this helpful?
References
1.-
Dhaliwal JS, Spurling BC, Molla M. Duloxetine. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31747213. https://pubmed.ncbi.nlm.nih.gov/31747213/
2.-
Schagen van Leeuwen JH, Lange RR, Jonasson AF, Chen WJ, Viktrup L. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. Maturitas. 2008 Jun 20;60(2):138-47. doi: 10.1016/j.maturitas.2008.04.012. Epub 2008 Jun 10. PMID: 18547757. https://pubmed.ncbi.nlm.nih.gov/18547757/
3.-
Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, Brown JP. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract. 2011 Jan-Feb;11(1):33-41. doi: 10.1111/j.1533-2500.2010.00401.x. PMID: 20602715. https://pubmed.ncbi.nlm.nih.gov/20602715/
Find a supportive therapist who can help with Depression.
Discover the convenience of BetterHelp, an online therapy platform connecting you with licensed and accredited therapists specialized in addressing issues such as depression, anxiety, relationships, and more. Complete the assessment and find your ideal therapist within just 48 hours.
AskYourPharm is user-supported. We may earn a commission if you sign up for BetterHelp’s services after clicking through from this site
